It is a pharma public limited company based in Sanand, Gujarat, India, established in 2010.
2010 | Sanand, Gujarat, India | ActiveTaurus Life Sciences Limited, a active public limited company, was established on 16 June 2010 in Sanand, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100GJ2010PLC061119. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.75 M.
It upholds a compliant status. Its leadership includes Harishbhai Keshavbhai Lathiya (Director), Mitaben Harishbhai Lathiya (Director), Vaidik Manshukhbhai Parsana (Director). Past directors included Harishbhai Keshavbhai Lathiya, Harsh Harishbhai Lathiya, Dipesh Arvindbhai Patel. It holds ₹5.60 Cr open charges and ₹6.36 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-50, Gallops Industrial Estate,, Near Meldi Mata Mandir,, Sanand, Gujarat, 382213.
U24100GJ2010PLC061119
061119
16 June 2010
₹1.00 Cr
₹9.75 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Taurus Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harishbhai Keshavbhai Lathiya | Director | 11 Oct 2021 | Current |
| Mitaben Harishbhai Lathiya | Director | 16 Jun 2010 | Current |
| Vaidik Manshukhbhai Parsana | Director | 23 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jul 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Taurus Life Sciences Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 20.43% decrease. The company also saw a substantial improvement in profitability, with a 18.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Taurus Life Sciences had a promoter holding of 99.69% and a public holding of 0.31%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹56,000,000.00
₹63,550,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2025 | Others | ₹1.50 Cr | Open |
| 02 Jun 2022 | Others | ₹4.10 Cr | Open |
| 09 Jul 2020 | Others | ₹3.70 M | Satisfied |
| 22 Oct 2019 | Others | ₹2.88 Cr | Satisfied |
| 07 May 2014 | Others | ₹1.60 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Taurus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Taurus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taurus Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101150219 was registered on 04 Aug 2025. was documented.
Progress on Taurus Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge registered on 09 Jul 2020 via Charge ID 100350249 with Others was fully satisfied on 24 Jul 2024. was recorded as a recent event.
Progress on A charge registered on 07 May 2014 via Charge ID 10494639 with Others was fully satisfied on 24 Jul 2024. was documented.
Progress on Taurus Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Vaidik Manshukhbhai Parsana was appointed as a Director was appointed as a Director on 23 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
The CIN of Taurus Life Sciences Limited is U24100GJ2010PLC061119.
Taurus Life Sciences Limited is headquartered at C-50, Gallops Industrial Estate,, Near Meldi Mata Mandir,, Sanand, Gujarat, 382213.
Taurus Life Sciences Limited was incorporated on 16 June 2010.
The current directors of Taurus Life Sciences Limited are
The primary industry of Taurus Life Sciences Limited is Manufacturing.
Taurus Life Sciences Limited is unlisted.
The authorized capital of Taurus Life Sciences Limited is ₹1.00 Cr, and the paid-up capital is ₹9.75 M.
The compliance status of Taurus Life Sciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX